Stock Titanยท54 event signal
Family trusts sell 1,723 United Therapeutics (UTHR) shares under a pre-arranged plan.
Family trusts linked to Martine A. Rothblatt, Chairperson & CEO of United Therapeutics (UTHR), sold 1,723 common shares on November 4, 2026, under a pre-arranged Rule 10b5-1 trading plan. The sales occurred at weighted-average prices ranging from $610.2928 to $613.1350 per share. This trading plan is scheduled to continue until the earlier of exercising 1,734,410 stock options or December 31, 2026.
Put this headline into context
Use TradingAgents AI to connect the story to the company's filings, fundamentals, market structure, competing bull and bear arguments, and risk review.
Source: Alpha VantageRead at Stock Titan
Headlines and excerpts belong to the original publisher. Ticker associations are informational and may be incomplete. Market news is not personalized financial advice.